scispace - formally typeset
P

Pooja Jain

Researcher at Drexel University

Publications -  89
Citations -  2219

Pooja Jain is an academic researcher from Drexel University. The author has contributed to research in topics: Immune system & Dendritic cell. The author has an hindex of 24, co-authored 82 publications receiving 1761 citations. Previous affiliations of Pooja Jain include Central Drug Research Institute.

Papers
More filters
Journal ArticleDOI

Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin.

TL;DR: This review focuses on the anti-inflammatory actions of flavonoids against chronic illnesses such as cancer, diabetes, cardiovascular diseases, and neuroinflammation with a special focus on apigenin, a relatively less toxic and non-mutagenic flavonoid with remarkable pharmacodynamics.
Journal ArticleDOI

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.

TL;DR: CNS recruitment of DCs correlates with disease severity in EAE via CCL2 chemotaxis and paracellular transmigration across the BBB, which is facilitated by ERK activation.
Journal ArticleDOI

DC-SIGN Mediates Cell-Free Infection and Transmission of Human T-Cell Lymphotropic Virus Type 1 by Dendritic Cells

TL;DR: It is suggested that DC-SIGN plays a critical role in HTLV-1 binding, transmission, and infection, thereby providing an attractive target for the development of antiretroviral therapeutics and microbicides.
Journal ArticleDOI

Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis.

TL;DR: This study shows that during EAE, especially immature DCs migrate into the CNS, where they may be crucial for the perpetuation of the CNS-targeted autoimmune response, and therapeutic targeting of α4 integrins affects DC trafficking intothe CNS and may therefore lead to the resolution ofThe CNS autoimmune inflammation by reducing the number of CNS professional APCs.